4.5 Article

Coverage for High-Cost Specialty Drugs for Rheumatoid Arthritis in Medicare Part D

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Editorial Material Medicine, General & Internal

Drug Companies' Patient-Assistance Programs - Helping Patients or Profits?

David H. Howard

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Rheumatology

Cost-related Medication Nonadherence in Older Patients with Rheumatoid Arthritis

Leslie R. Harrold et al.

JOURNAL OF RHEUMATOLOGY (2013)

Article Medicine, General & Internal

Receipt of Disease-Modifying Antirheumatic Drugs Among Patients With Rheumatoid Arthritis in Medicare Managed Care Plans

Gabriela Schmajuk et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)

Article Medicine, Research & Experimental

Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries

Ewa Orlewska et al.

MEDICAL SCIENCE MONITOR (2011)

Article Health Care Sciences & Services

Cost Sharing, Family Health Care Burden, and the Use of Specialty Drugs for Rheumatoid Arthritis

Pinar Karaca-Mandic et al.

HEALTH SERVICES RESEARCH (2010)

Article Rheumatology

Impact of Medicare Part D on Access to and Cost Sharing for Specialty Biologic Medications for Beneficiaries With Rheumatoid Arthritis

Jennifer M. Polinski et al.

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)

Letter Biotechnology & Applied Microbiology

Medicare formulary coverage for top-selling biologics

Su-Ying Liang et al.

NATURE BIOTECHNOLOGY (2009)

Editorial Material Rheumatology

NICE guidelines on anti-tumor necrosis factor therapy for RA

David L. Scott et al.

NATURE CLINICAL PRACTICE RHEUMATOLOGY (2009)

Article Rheumatology

Compliance With Biologic Therapies for Rheumatoid Arthritis: Do Patient Out-of-Pocket Payments Matter?

S. Curkendall et al.

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)

Article Rheumatology

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States

Charles G. Helmick et al.

ARTHRITIS AND RHEUMATISM (2008)

Article Health Care Sciences & Services

Benefit design and specialty drug use

Dana P. Goldman et al.

HEALTH AFFAIRS (2006)